Advertisement

ADVERTISEMENT

Arthur Allen

News
Why the CDC Has Recommended New Covid Boosters for All
09/15/2023
As COVID-19 hospitalizations tick upward with fall approaching, the CDC says it’s time for new boosters, and not only for those at highest risk of serious disease. Here are seven things you need to know.
As COVID-19 hospitalizations tick upward with fall approaching, the CDC says it’s time for new boosters, and not only for those at highest risk of serious disease. Here are seven things you need to know.
As COVID-19 hospitalizations...
09/15/2023
Pharmacy Learning Network
News
Pharmacists Say Administration's Limit on PBMs Backfired
11/17/2023
According to pharmacists, the Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring—heavily impacting independent drugstores, which is...
According to pharmacists, the Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring—heavily impacting independent drugstores, which is...
According to pharmacists, the...
11/17/2023
Pharmacy Learning Network
News
A New Test Could Save Arthritis Patients Time, Money, and Pain. But Will It Be Used?
12/21/2023
How insurers will respond to the availability of tests isn’t clear, partly because the arrival of new biosimilar drugs — essentially generic versions — are making TNFis cheaper for insurance plans. While Humira still dominates, AbbVie has...
How insurers will respond to the availability of tests isn’t clear, partly because the arrival of new biosimilar drugs — essentially generic versions — are making TNFis cheaper for insurance plans. While Humira still dominates, AbbVie has...
How insurers will respond to the...
12/21/2023
Pharmacy Learning Network
News
Will RSV Treatment Be Covered Under Vaccines for Children Program?
02/06/2023
The Centers for Disease Control and Prevention are assessing whether a monoclonal antibody therapy for respiratory syncytial virus should be eligible for federal funding and distribution.
The Centers for Disease Control and Prevention are assessing whether a monoclonal antibody therapy for respiratory syncytial virus should be eligible for federal funding and distribution.
The Centers for Disease Control...
02/06/2023
Pharmacy Learning Network
News
Pfizer CEO Pushes COVID-19 Boosters Amid Ongoing Debate
03/21/2022
Pfizer has requested authorization from the FDA for a second COVID-19 booster for people aged 65 years and older, but some experts disagree on whether there is yet enough data to support additional shots.
Pfizer has requested authorization from the FDA for a second COVID-19 booster for people aged 65 years and older, but some experts disagree on whether there is yet enough data to support additional shots.
Pfizer has requested...
03/21/2022
Pharmacy Learning Network
News
Patient Access, Inspection Challenges Arise as Generic Oncology Drug Production Decreases
06/23/2023
An ongoing decline in generic oncology drug production has created medication access difficulties for US patients.
An ongoing decline in generic oncology drug production has created medication access difficulties for US patients.
An ongoing decline in generic...
06/23/2023
Pharmacy Learning Network
News
Pfizer Earned $81.3 Billion in 2021
07/07/2022
Amidst the COVID-19 pandemic, Pfizer doubled its revenue from 2020 to 2021.
Amidst the COVID-19 pandemic, Pfizer doubled its revenue from 2020 to 2021.
Amidst the COVID-19 pandemic,...
07/07/2022
First Report Managed Care
News
Boost Now or Wait? Many Wonder How Best to Ride Out Next COVID-19 Wave
07/19/2022
Rapid mutations and distrust of the CDC and government officials have created challenges for fully immunizing the public.
Rapid mutations and distrust of the CDC and government officials have created challenges for fully immunizing the public.
Rapid mutations and distrust of...
07/19/2022
Pharmacy Learning Network
Patient Care
As Infections Grow Worse, Drug Companies Lose Interest in Antibiotics
07/22/2022
After mostly declining during the previous decade, the incidence rates of 7 deadly antimicrobial-resistant organisms surged in 2020 because of overuse in COVID-19 patients.
After mostly declining during the previous decade, the incidence rates of 7 deadly antimicrobial-resistant organisms surged in 2020 because of overuse in COVID-19 patients.
After mostly declining during...
07/22/2022
EMSWorld
News
FDA Accelerated Approval Process Raises Controversy Over Drug Prices, Effectiveness
09/30/2022
The US Food and Drug Administration's accelerated approval pathway allows for drugs to reach patients with unmet needs faster but has raised concerns in the medical community.
The US Food and Drug Administration's accelerated approval pathway allows for drugs to reach patients with unmet needs faster but has raised concerns in the medical community.
The US Food and Drug...
09/30/2022
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use